An international collaboration between researchers from India and the UK has developed an AI tool called HISTO-UNet. This framework differentiates and maps cancer cells from healthy cells, outperforming standard models across three major datasets. Crucially, the tool provides doctors with a reliable indicator to ensure only cancer cells are targeted, aiding in better patient recovery.